1. Home
  2. NRT vs PLUR Comparison

NRT vs PLUR Comparison

Compare NRT & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NRT

North European Oil Royality Trust

HOLD

Current Price

$6.25

Market Cap

57.0M

Sector

Energy

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.04

Market Cap

34.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRT
PLUR
Founded
1975
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.0M
34.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NRT
PLUR
Price
$6.25
$3.04
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
63.6K
47.2K
Earning Date
12-30-2025
11-12-2025
Dividend Yield
12.90%
N/A
EPS Growth
24.05
N/A
EPS
0.59
N/A
Revenue
$6,184,173.00
$1,326,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
$10.59
N/A
Revenue Growth
18.55
121.74
52 Week Low
$3.88
$3.02
52 Week High
$6.95
$7.13

Technical Indicators

Market Signals
Indicator
NRT
PLUR
Relative Strength Index (RSI) 55.76 38.75
Support Level $6.10 $3.10
Resistance Level $6.61 $3.92
Average True Range (ATR) 0.26 0.31
MACD 0.00 -0.03
Stochastic Oscillator 66.25 7.03

Price Performance

Historical Comparison
NRT
PLUR

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: